AhR Agonists for Psoriasis: A Novel Mechanism for Treatment of PsO
Psoriasis is a difficult disease to manage due to a variety of factors including fluctuations in disease severity, limited treatment options, and a limited understanding of the pathogenesis of disease.
Category
- LivDerm
- TME
Format
- Self-study / Enduring
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation